Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients
- PMID: 35833963
- PMCID: PMC9581829
- DOI: 10.1007/s00066-022-01975-6
Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients
Abstract
Purpose: Radiotherapy (RT) constitutes a mainstay in the treatment of elderly patients with head and neck cancer (HNC), but use of simultaneous chemoradiotherapy (CRT) remains controversial. We have conducted a prospective analysis based on real-world patient data to examine the health-related quality of life (HRQoL) and cost effectiveness (CE) of CRT vs. RT in elderly HNC patients.
Methods: Eligible participants ≥ 65 years treated in a large tertiary cancer center between July 2019 and February 2020 who completed the validated EQ-5D-5L questionnaire (health state index [HI] and visual analog scale [VAS]) before and after RT were included. CE referred to direct medical costs, including diagnosis-related group (DRG)-based billings for inpatients and uniform assessment standard (EBM)-based costs for outpatients. The primary endpoint was cost (euros [€]) per quality-adjusted life year (QALY). The incremental cost-effectiveness ratios (ICERs) were calculated. Costs and QALYs were not discounted for short overall survival (OS).
Results: Baseline HRQoL was 0.878 (±0.11) in the CRT group and 0.857 (±0.17) in the RT group. Upon completion of therapy, HRQoL amounted to 0.849 (±0.14) in the CRT and 0.850 (±0.13) in the RT group. The mean treatment-related cost in the CRT cohort was €22,180.17 (±8325.26) vs. €18,027.87 (±26,022.48) in the RT group. The corresponding QALYs amounted to 2.62 in the CRT and 1.91 in the RT groups. The ICER was €5848.31.
Conclusion: This is the first analysis from the German health care system demonstrating that the addition of chemotherapy to RT for selected elderly HNC patients is cost effective and not associated with a significant HRQoL decline.
Keywords: Chemoradiation; EQ‑5D; Geriatric patients; Head and neck squamous cell carcinoma; Quality-adjusted life year.
© 2022. The Author(s).
Conflict of interest statement
T. Sprave, V. Verma, A. Fabian, A. Rühle, D. Baltas, A.-L. Grosu, and N.H. Nicolay declare that they have no competing interests.
Figures
Similar articles
-
Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study.BMC Cancer. 2022 Nov 29;22(1):1236. doi: 10.1186/s12885-022-10346-4. BMC Cancer. 2022. PMID: 36447175 Free PMC article.
-
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):396-402. doi: 10.1016/j.ijrobp.2020.12.021. Epub 2020 Dec 23. Int J Radiat Oncol Biol Phys. 2021. PMID: 33359567 Clinical Trial.
-
Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):850-857. doi: 10.1016/j.ijrobp.2016.11.048. Epub 2016 Dec 2. Int J Radiat Oncol Biol Phys. 2017. PMID: 28258889
-
Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.Clin Otolaryngol. 2020 May;45(3):342-349. doi: 10.1111/coa.13501. Epub 2020 Feb 20. Clin Otolaryngol. 2020. PMID: 31869000
-
Global Incidence, Mortality, and Risk Factors of Stroke in Multi-Modality Head and Neck Cancer Treatment-A Systematic Review and Meta-Analysis.Head Neck. 2025 May;47(5):1520-1540. doi: 10.1002/hed.28109. Epub 2025 Feb 12. Head Neck. 2025. PMID: 39943713
Cited by
-
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.Strahlenther Onkol. 2024 Mar;200(3):208-218. doi: 10.1007/s00066-023-02132-3. Epub 2023 Sep 2. Strahlenther Onkol. 2024. PMID: 37658924 Free PMC article.
-
App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial.J Med Internet Res. 2023 Oct 19;25:e46189. doi: 10.2196/46189. J Med Internet Res. 2023. PMID: 37856185 Free PMC article. Clinical Trial.
-
Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation.Cancers (Basel). 2022 Nov 10;14(22):5536. doi: 10.3390/cancers14225536. Cancers (Basel). 2022. PMID: 36428629 Free PMC article.
References
-
- van den Bussche H, Kaduszkiewicz H, Schafer I, Koller D, Hansen H, Scherer M, et al. Overutilization of ambulatory medical care in the elderly German population?—An empirical study based on national insurance claims data and a review of foreign studies. BMC Health Serv Res. 2016;16:129. doi: 10.1186/s12913-016-1357-y. - DOI - PMC - PubMed
-
- Ebert N, Kensche A, Lock S, Hadiwikarta WW, Hansch A, Dorr W, et al. Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus(R) tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy. Strahlenther Onkol. 2021;197:63–73. doi: 10.1007/s00066-020-01684-y. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials